The invention is concerned with novel piperazine amide derivatives of formula (I)
wherein R
1
to R
11
, W, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds bind to LXR alpha and LXR beta and can be used as medicaments.